GERMLINE BRCA1 GENE MUTATION

Clinical trials for GERMLINE BRCA1 GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new GERMLINE BRCA1 GENE MUTATION trials appear

Sign up with your email to follow new studies for GERMLINE BRCA1 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for when standard breast cancer drugs stop working

Disease control Recruiting now

This study is testing two new drug combinations for people with advanced, BRCA-positive breast cancer that has spread and has stopped responding to a standard type of targeted therapy (PARP inhibitors). The trial will see if adding a second drug to the standard one can shrink tum…

Matched conditions: GERMLINE BRCA1 GENE MUTATION

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

GERMLINE BRCA1 GENE MUTATION

Get alerted when new GERMLINE BRCA1 GENE MUTATION trials appear

New hope for when standard breast cancer drugs stop working